Flow Cytometric Assessment of CD26-Positive Leukemic Stem Cells: A Rapid and Valuable Tool in the Diagnosis and Follow-Up of Chronic Myeloid Leukemia. This evidence concerns the gene DPP4 and chronic myelogenous leukemia, BCR-ABL1 positive.